ID   CHLA-51
AC   CVCL_6604
DR   Cosmic; 930040
DR   Cosmic; 1161982
DR   Wikidata; Q54812499
RX   PubMed=9850071;
RX   PubMed=11212268;
RX   PubMed=11507071;
RX   PubMed=18724359;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 15,18
ST   D19S433: 14,14.2
ST   D21S11: 30
ST   D2S1338: 21,23
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 19,22
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 12
//
RX   PubMed=9850071;
RA   Keshelava N., Seeger R.C., Groshen S., Reynolds C.P.;
RT   "Drug resistance patterns of human neuroblastoma cell lines derived
RT   from patients at different phases of therapy.";
RL   Cancer Res. 58:5396-5405(1998).
//
RX   PubMed=11212268;
RA   Thompson P.M., Maris J.M., Hogarty M.D., Seeger R.C., Reynolds C.P.,
RA   Brodeur G.M., White P.S.;
RT   "Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36
RT   or at other tumor suppressor loci in neuroblastoma.";
RL   Cancer Res. 61:679-686(2001).
//
RX   PubMed=11507071;
RA   Keshelava N., Zuo J.J., Chen P., Waidyaratne S.N., Luna M.C.,
RA   Gomer C.J., Triche T.J., Reynolds C.P.;
RT   "Loss of p53 function confers high-level multidrug resistance in
RT   neuroblastoma cell lines.";
RL   Cancer Res. 61:6185-6193(2001).
//
RX   PubMed=18724359; DOI=10.1038/nature07261;
RA   Mosse Y.P., Laudenslager M., Longo L., Cole K.A., Wood A.,
RA   Attiyeh E.F., Laquaglia M.J., Sennett R., Lynch J.E., Perri P.,
RA   Laureys G., Speleman F., Kim C., Hou C.-P., Hakonarson H., Torkamani A.,
RA   Schork N.J., Brodeur G.M., Tonini G.P., Rappaport E., Devoto M.,
RA   Maris J.M.;
RT   "Identification of ALK as a major familial neuroblastoma
RT   predisposition gene.";
RL   Nature 455:930-935(2008).
//